Lineage Cell Therapeutics, Inc.LCTXNYSE
LOADING
|||
ROE: Strong Returns
Trending higher, above historical average, structural decline.
Left:
||||
Return on equity
Latest
-23.74%
↑ 37% above average
Average (9y)
-37.95%
Historical baseline
Range
High:28.47%
Low:-174.75%
CAGR
-19.9%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | -23.74% | +29.9% |
| 2023 | -33.88% | +5.4% |
| 2022 | -35.82% | +23.2% |
| 2021 | -46.65% | -117.3% |
| 2020 | -21.46% | -107.1% |
| 2019 | -10.37% | +78.8% |
| 2018 | -49.01% | -299.0% |
| 2017 | -12.28% | -143.1% |
| 2016 | 28.47% | +116.3% |
| 2015 | -174.75% | - |